Stay updated on Inhaled ZYESAMI Clinical Trial
Sign up to get notified when there's something new on the Inhaled ZYESAMI Clinical Trial page.

Latest updates to the Inhaled ZYESAMI Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded metadata entries including the keyword 'Pathogenesis of COVID-19 from a cell biologic perspective' and sponsor-related notes ('APR Applied Pharma Research s.a.'; 'Helpful Links Provided by APR'), and updated the revision from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check18 days agoChange DetectedRemoved the 'Pathogenesis of COVID-19 from a cell biologic perspective' section and the sponsor/credit information for APR Applied Pharma Research s.a., as well as the 'Helpful Links Provided by' label from the study page.SummaryDifference0.1%

- Check32 days agoChange DetectedRevision update: v3.5.0 replaces the previous v3.4.3.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a minor technical update with no substantive changes to the study details.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision: v3.4.2 is now displayed, indicating updated content for the study page. The government funding/operating status notice was removed.SummaryDifference0.4%

- Check82 days agoChange DetectedA site-wide funding notice was added, informing users about a lapse in government funding and the NIH Clinical Center's operating status. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Inhaled ZYESAMI Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled ZYESAMI Clinical Trial page.